LDS/Medical Tests/Opium, Urine

Opium, Urine

Opium is a complex mixture of more than 20 alkaloids that are obtained from Papaver somniferum (the opium poppy). The exact composition of opium varies from one geographical region to another, but the more major constituents are morphine, noscapine, papaverine, codeine, and thebaine. Morphine and codeine are the major active constituents of opium. The remaining constituents of opium such as Noscapine (narcotine) and papaversine do not produce morphine-like euphoric effects. Noscapine produces an antitussive effect, and papaversine possesses vasodilator properties. Thebaine is mainly used as the starting material for the synthesis of other opioids. Historically opium has been administered by oral, rectal, or intranasal routes, as well as through smoking. Opium contributed to particularly significant social and public health demise in China historically, especially during the Opium Wars in the 1830s through 1860s. There are no clinical laboratory tests that distinguish opium from opioids that contain or are metabolized to morphine and codeine. Consult the laboratory testing options for morphine and codeine for more information and guidance on pharmacokinetics and testing options.

  • Therapeutic monitoring
  • Drug abuse evaluation
  • Toxicity assessment
A qualitative positive result from either Thin Layer Chromatography (TLC) or immunoassay (IA) type test indicates only the presence of Opium and does not necessarily correlate with the extent of physiological and psychological effects. Any positive result should be confirmed by a non-immunological method such as GC, TLC, LC/MS or GC/MS.

Therapeutic Level: 10-100 ng/mL
Toxic level: >200 ng/mL                          

Note: therapeutic ranges and toxic thresholds are best evaluated from blood samples. Quantitative results obtained with blood samples collected at specific times after drug administration are preferred for pharmacokinetic analyses.

Cut-Off Ranges
Cut-off values are used to determine the positivity of the urine specimen being analyzed. Cut-off values can vary based on the particular method of analysis that is used for detection whether it is a qualitative method such as TLC, or IA, or a quantitative method, such as LC/MS or GC/MS. The testing laboratory cut-off range is listed on the patient report. Consult your physician for further information or click on one of the references that are listed below.

Liquid Chromatography/Mass Spectroscopy (LC/MS), Gas Chromatography/Mass Spectroscopy (GC/MS), Thin Layer Chromatography (TLC), or Immunoassay (IA). The main method of quantitation detection is via LC/MS or LC/MS/MS (liquid chromatography coupled with mass spectroscopy). This particular method of analysis is used to not only detect the parent drug class of opiates, but also the major metabolites. Opium and its metabolites can be separated from biological specimens by liquid-liquid extraction or by solid-phase extraction. Their metabolism takes place primarily in the liver to form mostly polar metabolites, which are eliminated via enterohepatic or renal recirculation. These glucuronide conjugates are excreted primarily in the urine. When analyzing urine specimens a hydrolysis step is required to free the parent drug and metabolites from glucuronide conjugates. Enzymatic hydrolysis is preferred over acid hydrolysis.

Fresh urine specimen collected in either a clean glass or plastic container. An acceptable urine specimen submitted for testing should be in the pH range of 3-11. Adulteration of the urine specimen can result in erroneous results.

Stability

  • Ambient: 3-5 days
  • Refrigerated: 5-7 days
  • Frozen: 30 days
Pain drug management pharmacogenomics panel or CYP3A4, CYP3A5, CYP2D6 should be tested for drug safety and efficacy before ordered. Supportive testing such as Liver profile, Kidney profile, Comprehensive Metabolic Panel, CBC (if overdose), other drugs if necessary.
1-3 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Cell Mol Nuerobiol. 2008;28(4):479-90. [PMID: 17990098]
  • Wu A (ed). Tietz Clinical Guide to Laboratory Tests, 4th ed. Philadelphia: WB Saunders; 2006.
  • Baselt RC (ed). Analytical procedures for therapeutic drug monitoring and emergency toxicology, 2nd ed. Littleton, MA: PSG Publishing Co.; 1987.
  • Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 9th ed. Foster City, CA: Biomedical Publications; 2011.
  • Baselt RC (ed). Disposition of toxic drugs and chemicals in man, 6th ed. Foster City, CA:Biomedical Publications; 2002.
  • Levine B (ed). Miscellaneous Central Nervous System Depressants. In: Principles of Forensic Toxicology, 4th Ed. Washington DC: AACC Press, Washington DC; 2013:261-270.